|Anti-hIL-29-IgG||Unit size||Cat. code||Docs||Qty||Price|
Human IL-29 Neutralizing antibody - Monoclonal Mouse IgG2a
3 x 100 µg
Neutralizing monoclonal antibody against human interleukin 29
Anti-hIL-29-IgG is a monoclonal antibody against human interleukin 29 (hIL-29).
This antibody has been selected for its ability to efficiently neutralize the biological activity of hIL-29.
Anti-hIL-29-IgG is produced in hybridomas and purified by affinity chromatography.
Neutralizing activity of IFN-λ antibodies: HEK-Blue™ IFN-α/β cells were incubated with 10 ng/ml recombinant hIL-28a, hIL28b, hIL-29 and increasing concentrations of their cognate antibody. After 24h incubation, recombinant IFN-λ induced ISG activation was assessed by measuring SEAP levels in the supernatant using QUANTI-Blue™. Percentages of maximal response (no antibody) and IC50 for 10 ng/ml of each cytokine is shown.
Target: natural and recombinant human interleukin-29 (IL-29)
Specificity: Reacts with human IL-28A and human IL-28B.
No cross-reactivity with mouse IL-28A or mouse IL-28B.
Note: An active IL-29 gene is absent in mice.
Isotype: Mouse IgG2a, kappa
Control: Mouse IgG2a Control
Immunogen: Human IL-29 protein expressed in Swiss mice following DNA immunization
Formulation: 0.2 µm filtered solution in Tris HCl buffer with saccharose, glycine and stabilizing agents
Tested applications: Blocking & NeutralisationBack to the top
- 3 x 100 μg purified anti-hIL-29-IgG antibody, provided azide-free and lyophilized
Product is shipped at room temperature.
Store lyophilized antibody at -20 °C.Back to the top